Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Hangzhou Nurotron Biotech Cuts Cost of Cochlear Implant

publication date: Apr 3, 2013

Hangzhou Nurotron Biotechnology has developed a less expensive cochlear implant, a medical device that allows severely deaf people to hear again. In China, the company offers a $16,000 implant, half the cost of the market-leading Australian import, a $32,000 device from Cochlear Ltd. Nurotron is headquartered in Hangzhou, where it also has a manufacturing facility. But its R&D operation is in Irvine, California, close to the home of its founder, Fan-Gang Zeng, PhD, the Director of the Center for Hearing Research at University of California at Irvine. More details....

Stock Symbol: (ASX: COH)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital